These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7650075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 3. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD000307. PubMed ID: 15674872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A, Ba B, Durand A, Gouezo F, Hou N, Jørgensen A.
    Psychopharmacology (Berl); 1988 Jan 25; 94(3):293-7. PubMed ID: 2895936
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW, Ereshefsky L, Saklad SR.
    Clin Pharmacokinet; 1985 Jan 25; 10(4):315-33. PubMed ID: 2864156
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
    Soni SD, Wiles D, Schiff AA, Bamrah JS.
    Br J Psychiatry; 1988 Sep 25; 153():382-4. PubMed ID: 3250675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
    Dudley J, Rauw G, Hawes EM, Keegan DL, Midha KK.
    Prog Neuropsychopharmacol Biol Psychiatry; 1983 Sep 25; 7(4-6):791-5. PubMed ID: 6686710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate.
    Marder SR, Hawes EM, Van Putten T, Hubbard JW, McKay G, Mintz J, May PR, Midha KK.
    Psychopharmacology (Berl); 1986 Sep 25; 88(4):480-3. PubMed ID: 3085136
    [Abstract] [Full Text] [Related]

  • 17. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
    Norman TR, Marriott PF, Kimber NM, Burrows GD.
    Int Clin Psychopharmacol; 1987 Oct 25; 2(4):299-305. PubMed ID: 3693869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH, Gelder MG.
    Br J Clin Pharmacol; 1979 Dec 25; 8(6):565-70. PubMed ID: 533577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.